Cue Biopharma, Inc. logo

Cue Biopharma, Inc.

NASDAQ:CUE

Overview | Financials
Company Name Cue Biopharma, Inc.
Symbol CUE
Currency USD
Price 1.52
Market Cap 91,515,704
Dividend Yield 0%
52-week-range 0.45 - 3.249
Industry Biotechnology
Sector Healthcare
CEO Mr. Daniel R. Passeri J.D., M.Sc., MSc.
Website https://www.cuebiopharma.com

An error occurred while fetching data.

About Cue Biopharma, Inc.

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to

Related Stocks

Gamida Cell Ltd. logo

Gamida Cell Ltd.

GMDA

0.033 USD

CorMedix Inc. logo

CorMedix Inc.

CRMD

9.99 USD

Gritstone bio, Inc. logo

Gritstone bio, Inc.

GRTS

0.032 USD

ORIC Pharmaceuticals, Inc. logo

ORIC Pharmaceuticals, Inc.

ORIC

9.41 USD

Apyx Medical Corporation logo

Apyx Medical Corporation

APYX

1.19 USD

Ovid Therapeutics Inc. logo

Ovid Therapeutics Inc.

OVID

1.14 USD

Financials

Numbers are in millions USD

Numbers are in millions USD